[1] Abman SH, Bancalari E, Jobe A. The evolution of bronchopulmonary dysplasia after 50 years[J]. Am J Respir Crit Care Med,2017,195(4):421-424. [2] Thébaud B, Goss KN, Laughon M, et al. Bronchopulmonary dysplasia[J]. Nat Rev Dis Primers,2019,5(1):78. [3] Schittny JC. Development of the lung[J]. Cell Tissue Res,2017,367(3):427-444. [4] Shukla VV, Ambalavanan N. Recent advances in bronchopulmonary dysplasia[J]. Indian J Pediatr,2021,88(7):690-695. [5] Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993—2012[J]. JAMA,2015,314(10):1039-1051. [6] 江苏省新生儿重症监护病房母乳质量改进临床研究协作组. 多中心回顾性分析极低及超低出生体重儿支气管肺发育不良的临床特点及高危因素 [J].中华儿科杂志,2019, 57(1):33-39. Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units. Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia:Multicenter retrospective analysis[J]. Chin J Pediatr, 2019, 57(1):33-39. [7] Homan TD, Nayak RP. Short- and long-term complications of bronchopulmonary dysplasia[J]. Respir Care,2021,66(10):1618-1629. [8] 张蕊, 郑黎强, 潘国伟. 疾病发病风险预测模型的应用与建立[J].中国卫生统计, 2015, 32(4):724-726. Zhang R, Zheng LQ, Pan GW. Application and establishment of disease risk prediction model[J]. Chin J Health Statistics, 2015, 32(4):724-726. [9] Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints:Preferred definitions and conceptual framework[J]. Clin Pharmacol Ther,2001,69(3):89-95. [10] Philpot PA, Bhandari V. Predicting the likelihood of bronchopulmonary dysplasia in premature neonates[J]. Expert Rev Respir Med,2019,13(9):871-884. [11] Pezza L, Alonso-Ojembarrena A, Elsayed Y, et al. Meta-analysis of lung ultrasound scores for early prediction of bronchopulmonary dysplasia[J]. Ann Am Thorac Soc,2022,19(4):659-667. [12] Shim SY, Yun JY, Cho SJ, et al. The prediction of bronchopulmonary dysplasia in very low birth weight infants through clinical indicators within 1 hour of delivery[J]. J Korean Med Sci,2021,36(11):e81. [13] Alvarez-Fuente M, Moreno L, Lopez-Ortego P, et al. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia[J]. PLoS One,2019,14(3):e0213210. [14] Valenzuela-Stutman D, Marshall G, Tapia JL, et al. Bronchopulmonary dysplasia:Risk prediction models for very-low-birth-weight infants[J]. J Perinatol,2019,39(9):1275-1281. [15] Balaji S, Dong X, Li H, et al. Sex-specific differences in primary neonatal murine lung fibroblasts exposed to hyperoxia in vitro:Implications for bronchopulmonary dysplasia[J]. Physiol Genomics,2018,50(11):940-946. [16] Cai H, Jiang L, Liu Y, et al. Development and verification of a risk prediction model for bronchopulmonary dysplasia in very low birth weight infants[J]. Transl Pediatr,2021,10(10):2533-2543. [17] Salimi U, Dummula K, Tucker MH, et al. Postnatal sepsis and bronchopulmonary dysplasia in premature infants:Mechanistic insights into "New BPD"[J]. Am J Respir Cell Mol Biol,2022,66(2):137-145. [18] Hamrick SEG, Sallmon H, Rose AT, et al. Patent ductus arteriosus of the preterm infant[J]. Pediatrics,2020,146(5):e20201209. [19] Su BH, Lin HY, Chiu HY, et al. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants[J]. Pediatr Neonatol,2020,61(2):133-141. [20] Wang J, Dong W. Oxidative stress and bronchopulmonary dysplasia[J]. Gene, 2018,678:177-183. [21] Perez M, Robbins ME, Revhaug C, et al. Oxygen radical disease in the newborn, revisited:Oxidative stress and disease in the newborn period[J]. Free Radic Biol Med,2019,142:61-72. [22] Dilli D, Özyazici A, Dursun A, et al. Predictive values of plasma KL-6 in bronchopulmonary dysplasia in preterm infants[J]. Turk J Med Sci,2017,47(2):621-626. [23] Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis[J]. J Med Invest,1999,46(3-4):151-158. [24] Yang Y, Li J, Mao J. Early diagnostic value of C-reactive protein as an inflammatory marker for moderate-to-severe bronchopulmonary dysplasia in premature infants with birth weight less than 1500 g[J]. Int Immunopharmacol, 2022,103:108462. [25] Ambalavanan N, Ross AC, Carlo WA. Retinol-binding protein, transthyretin, and C-reactive protein in extremely low birth weight (ELBW) infants[J]. J Perinatol,2005,25(11):714-719. [26] Griscom NT, Wheeler WB, Sweezey NB, et al. Bronchopulmonary dysplasia:Radiographic appearance in middle childhood[J]. Radiology,1989,171(3):811-814. [27] 任艳丽, 孔祥永, 杜志方, 等. 不同程度支气管肺发育不良早产儿的临床及影像学特点[J].中国当代儿科杂志, 2015, 17(5):440-444. Ren YL, Kong XY, Du ZF,et al. Clinical and imaging features of premature infants with different degrees of bronchopulmonary dysplasia[J]. Chin J Contemp Pediatr, 2015, 17(5):440-444. [28] Kim HR, Kim JY, Yun B, et al. Interstitial pneumonia pattern on day 7 chest radiograph predicts bronchopulmonary dysplasia in preterm infants[J]. BMC Pediatr,2017,17(1):125. [29] Semple T, Akhtar MR, Owens CM. Imaging bronchopulmonary dysplasia-A multimodality update[J]. Front Med (Lausanne),2017,29(4):88. [30] Tonson la Tour A, Spadola L, Sayegh Y, et al. Chest CT in bronchopulmonary dysplasia:Clinical and radiological correlations[J].Pediatr Pulmonol,2013,48(7):693-698. [31] Shin SM, Kim WS, Cheon JE, et al. Bronchopulmonary dysplasia:New high resolution computed tomography scoring system and correlation between the high resolution computed tomography score and clinical severity[J]. Korean J Radiol,2013,14(2):350-360. [32] Li R, Zhang J. Diagnostic value of chest CT combined with x-ray for premature infants with bronchopulmonary dysplasia[J]. Medicine (Baltimore),2018,97(9):e9723. [33] van Mastrigt E, Logie K, Ciet P, et al. Lung CT imaging in patients with bronchopulmonary dysplasia:A systematic review[J]. Pediatr Pulmonol,2016,51(9):975-986. [34] Brenner D, Elliston C, Hall E, et al. Estimated risks of radiation-induced fatal cancer from pediatric CT[J]. AJR Am J Roentgenol,2001,176(2):289-296. [35] Walkup LL, Woods JC. Newer imaging techniques for bronchopulmonary dysplasia[J]. Clin Perinatol,2015,42(4):871-887. [36] Higano NS, Spielberg DR, Fleck RJ, et al. Neonatal pulmonary magnetic resonance imaging of bronchopulmonary dysplasia predicts short-term clinical outcomes[J]. Am J Respir Crit Care Med,2018,198(10):1302-1311. [37] Mulkern R, Haker S, Mamata H, et al. Lung parenchymal signal intensity in MRI:A technical review with educational aspirations regarding reversible versus irreversible transverse relaxation effects in common pulse sequences[J]. Concepts Magn Reson Part A Bridg Educ Res,2014,43A(2):29-53. [38] Alonso-Ojembarrena A, Lubián-López SP. Lung ultrasound score as early predictor of bronchopulmonary dysplasia in very low birth weight infants[J]. Pediatr Pulmonol,2019,54(9):1404-1409. [39] Lalitha R, Bitar E, Hicks M, et al. Pulmonary artery dopplers for early prediction of risk for bronchopulmonary dysplasia in extremely low birth weight babies[J]. J Clin Ultrasound,2022,50(3):385-392. |